Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis

Mult Scler Relat Disord. 2017 Jan:11:1-3. doi: 10.1016/j.msard.2016.11.003. Epub 2016 Nov 11.

Authors

Tuncay Gündüz¹, Murat Kürtüncü¹, Mefkure Eraksoy¹

Affiliation

¹ Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Turkey.

PMID: 28104247
DOI: 10.1016/j.msard.2016.11.003

No abstract available

Keywords: Fingolimod withdrawal; Multiple sclerosis; Rebound disease activity.

Publication types

Case Reports

MeSH terms

Adult
Female
Fingolimod Hydrochloride / adverse effects*
Fingolimod Hydrochloride / therapeutic use
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / therapeutic use
Middle Aged
Multiple Sclerosis / diagnostic imaging
Multiple Sclerosis / drug therapy*

Substances

Immunosuppressive Agents
Fingolimod Hydrochloride